Live feed07:00:00·290dPRReleasevia QuantisnowIonis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndromeByQuantisnow·Wall Street's wire, on your screen.IONS· Ionis Pharmaceuticals Inc.Health Care
